CTA Policy Analyst Jaydee Hanson comments to FDA on regulation of nanotechnology
Posted in Regulations on October 6, 2006
October 6, 2006
Jaydee Hanson submitted these comments to the FDA docket on nanotechnology regulation. CTA coordinated comments to the FDA docket and succeeded in getting over 15,000 persons to comment on the docket Number 2006N-0107 “FDA-Regulated Products Containing Nanotechnology Materials.”
